OH and the leaf of the kratom plant are not analogous, but as the former is a derivative of the latter, it has opioid-like qualities that make its susceptibility to abuse concerning.

This regulatory relief, combined with several other compelling catalysts, creates a pathway for the stock to potentially ...

Shares of drugmaker Sarepta Therapeutics surged in afterhours trading Monday after the company said it would resume shipping ...

Sarepta Therapeutics (NASDAQ:SRPT) surges 40% post-market after strategic restructuring, workforce cuts, pipeline focus, and $400M cost-saving plans. Read more here.

Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label – After strategic review ...

FDA Issues Nationwide Recall for Popular Yogurt Brand Over a Serious Safety Threat originally appeared on Men's Fitness. Your go-to snack for hitting your protein goals may be part of a nationwide ...

Cockroaches, mice and beds without sheets were normal at Gabriel House in Fall River, a resident said a day after the deadly fire. “They didn’t care about people’s lives." ...

Consumers are urged to discard or return the affected products as the FDA warns that they could cause serious health issues or death.

The manufacturing-related rejection also delays a key test of the new FDA leadership’s support for cell and gene therapy against rare diseases.

The warning comes with a national advisory over a recall related to food safety.

The U.S. Food and Drug Administration (FDA) has issued a national advisory and classified a recent mushroom recall as Class I, the agency's highest level risk designation, due to potential ...